Advanced Hepatocellular Carcinoma With c-MET Dysregulation
1 clinical trials · Condition
◉ Watch Advanced Hepatocellular Carcinoma With c-MET Dysregulation
| Record | Firm | Date |
|---|---|---|
| Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma. (NCT01737827) | Novartis Pharmaceuticals | 2013-03-25 |
Track Advanced Hepatocellular Carcinoma With c-MET Dysregulation automatically
Every clearance here is in the API, with alerts when new ones post.